G Nappo
Overview
Explore the profile of G Nappo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rangelova E, Stoop T, van Ramshorst T, Ali M, van Bodegraven E, Javed A, et al.
Ann Oncol
. 2025 Jan;
PMID: 39814200
Background: Left-sided pancreatic cancer is associated with worse overall survival (OS) compared with right-sided pancreatic cancer. Although neoadjuvant therapy is currently seen as not effective in patients with resectable pancreatic...
2.
Giaccherini M, Giaccherini M, Rende M, Gentiluomo M, Gentiluomo M, Corradi C, et al.
Mutagenesis
. 2024 Apr;
PMID: 38606763
Pleiotropic variants (i.e., genetic polymorphisms influencing more than one phenotype) are often associated with cancer risk. A scan of pleiotropic variants was successfully conducted ten years ago in relation to...
3.
Ruggeri R, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, et al.
J Endocrinol Invest
. 2023 Oct;
47(4):959-971.
PMID: 37837555
Background: The incidence of neuroendocrine neoplasm (NEN) and related carcinoid syndrome (CaS) has increased markedly in recent decades, and women appear to be more at risk than men. As per...
4.
Donisi G, Nappo G, Pacilli M, Capretti G, Spaggiari P, Sollai M, et al.
Updates Surg
. 2023 Aug;
75(6):1497-1508.
PMID: 37578734
Neoadjuvant therapy (NAT) + surgical resection for pancreatic cancer (PC) has gained consensus in recent years. Pathological response (PR) is generally assessed according to the College of American Pathologists grading...
5.
Merola E, Pascher A, Rinke A, Bartsch D, Zerbi A, Nappo G, et al.
Ann Surg Oncol
. 2022 May;
29(9):5568-5577.
PMID: 35583694
Background: Surgery with radical intent is the only potentially curative option for entero-pancreatic neuroendocrine tumors (EP-NETs) but many patients develop recurrence even after many years. The subset of patients at...
6.
Nappo G, Galvanin J, Gentile D, Capretti G, Pulvirenti A, Bozzarelli S, et al.
Pancreatology
. 2021 Apr;
21(5):950-956.
PMID: 33795194
Background: Ampullary carcinoma (AC) is histologically classified as intestinal (In-AC), pancreaticobiliary (Pb-AC) or mixed-AC. The prognostic role of AC subtypes has been debated and remains unclear. The aims of this...
7.
Rossi R, Milanetto A, Andreasi V, Campana D, Coppa J, Nappo G, et al.
J Endocrinol Invest
. 2021 Mar;
44(10):2227-2234.
PMID: 33651317
Purpose: Pretreatment staging is the milestone for planning either surgical or endoscopic treatment in duodenal neuroendocrine neoplasms (dNENs). Herein, a series of surgically treated dNEN patients was evaluated to assess...
8.
Donisi G, Capretti G, Cortese N, Rigamonti A, Gavazzi F, Nappo G, et al.
J Transl Med
. 2020 Sep;
18(1):340.
PMID: 32883314
Background: Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough understanding of the pathogenesis of the...
9.
Capretti G, Nappo G, Smiroldo V, Cereda M, Branciforte B, Spaggiari P, et al.
Gastroenterol Res Pract
. 2019 Jun;
2019:6856329.
PMID: 31182959
Nodal involvement (actually categorized as positive or negative) is an important prognostic factor after surgery for pancreatic neuroendocrine neoplasms (pNENs). We aim to evaluate the predictive role of the number...
10.
Nappo G, Handle F, Santer F, McNeill R, Seed R, Collins A, et al.
Oncogenesis
. 2017 May;
6(5):e342.
PMID: 28553931
Interleukin-4 plays a critical role in the regulation of immune responses and has been detected at high levels in the tumour microenvironment of cancer patients, where concentrations correlate with the...